Showing results (181-190 of 217) with videos related to
Sort By:
Pageof 22
The Journal of Molecular Diagnostics : JMD|April 27, 2018
System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data ManagementWenjun Kang, Sabah Kadri, Rutika Puranik, et al.Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology GroupJudith G Villablanca, Wendy B London, Arlene Naranjo, et al.Cell Reports|May 1, 2024
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiationMonica Pomaville, Mohansrinivas Chennakesavalu, Pingluan Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with NeuroblastomaMark A Applebaum, Erin K Barr, Jason Karpus, et al.The Lancet. Oncology|July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trialSusan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.Journal of the American Medical Informatics Association : JAMIA|May 14, 2014
CAPriCORN: Chicago Area Patient-Centered Outcomes Research NetworkAbel N Kho, Denise M Hynes, Satyender Goel, et al.JCO Global Oncology|December 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups-Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group ProjectWendy B London, Gabriela Villanueva, Derek Shyr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Rochelle Bagatell, Susan L Cohn, et al.Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.Pageof 22